Cystic Fibrosis Trial, Recruiting (NCT05200429)

Cystic Fibrosis Trial, Recruiting NCT05200429 Sponsor: University of British Columbia Condition: Cystic Fibrosis

Printed from Voxsanity (voxsanity.com.au) — NCT05200429 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cystic Fibrosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been prescribed a cystic fibrosis medication called a CFTR modulator and are planning to start taking it within the next 30 days, or you are planning to switch to a different CFTR modulator within the next 30 days
You are already registered in the Canadian Cystic Fibrosis Registry (CCFR)
You (or your parent or legal guardian, if you are a child) have agreed to take part and given written consent

Who may not be able to join:

You have a medical reason why you should not take CFTR modulator therapy (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jonathan Rayment, MDCM, University of British Columbia

Phone: 604-875-2345

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05200429

Sponsor: University of British Columbia

Phase: Not Applicable

Status: Recruiting

Condition: Cystic Fibrosis

Trial contact: 604-875-2345

More information: https://clinicaltrials.gov/study/NCT05200429

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been prescribed a cystic fibrosis medication called a CFTR modulator and are planning to start taking it within the next 30 days, or you are planning to switch to a different CFTR modulator within the next 30 days
You are already registered in the Canadian Cystic Fibrosis Registry (CCFR)
You (or your parent or legal guardian, if you are a child) have agreed to take part and given written consent

Who may not be able to join:

You have a medical reason why you should not take CFTR modulator therapy (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of British Columbia

Registry

ClinicalTrials.gov

Start date

1 November 2021

Est. completion

31 December 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

To examine the long-term pulmonary and nutritional effects of CFTR modulators.; To assess the long-term impact of CFTR modulators on patient-reported outcome measures including quality of life, disease burden, and physical activity.; To establish a bio-repository to enable further investigations of the effectiveness of CFTR modulator therapies on biological markers and predictors of response.; To establish the benefits of CFTR modulators compared to propensity-score matched historic CF populations followed in the Canadian CF registry.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov